BACKGROUND: The role of the immune system in the control of tumour progression has been stressed, recently. Many studies indicate the fact that the immune system can prevent tumour progression in several types of human malignant neoplasms including colorectal cancer. According to some authors, a higher density of “tumour-associated lymphocytes†(TAL), in malignant neoplasms, correlate with prolonged survival of patients.AIM: This study aims to determine the structure and the influence of the immune cells, TAL, in the progression of colorectal cancer (CRC).PATIENTS AND METHODS: The study included 103 patients with CRC operated at the University Clinic of Digestive Surgery in Skopje, whose operative material was analysed at the Institute o...
Colorectal cancer (CRC) patients survive and stay free of disease for longer after surgery if their...
Solid tumours are commonly infiltrated by several immune cells [1-3]. In cancer, immune cells play c...
Objective: This study aimed to evaluate the immunohistochemical expression of forkhead boxP3 (Foxp3)...
Abstract Introduction: Tumor-infiltrating lymphocytes (TIL) in tumor stroma are considered to be in...
Inflammatory cells are involved in tumour initiation and progression. In parallel, the adaptive immu...
Tumour infiltrating lymphocytes influence colorectal cancer (CRC) progression. However, lymphocyte i...
Tumor-infiltrating lymphocytes (TILs) are vital elements of the tumor microenvironment (TME), and th...
Background: Colorectal cancer (CRC) is globally the second most common form of cancer among women, a...
Accumulating evidence demonstrates an association between dense infiltration of lymphocytes and prog...
Cancer-related immunity has been identified as playing a key role in the outcome of colorectal cance...
Worldwide, more than one million people are diagnosed with colorectal cancer (CRC) every year. Analy...
The anti-tumour immune response is critical to patient prognosis in colorectal cancer (CRC). The aim...
The anti-tumour immune response is critical to patient prognosis in colorectal cancer (CRC). The aim...
Background: Although high T cell density is a strong favourable prognostic factor in colorectal canc...
Several distinct innate lymphoid cell (ILC) populations have been recently identified and shown to p...
Colorectal cancer (CRC) patients survive and stay free of disease for longer after surgery if their...
Solid tumours are commonly infiltrated by several immune cells [1-3]. In cancer, immune cells play c...
Objective: This study aimed to evaluate the immunohistochemical expression of forkhead boxP3 (Foxp3)...
Abstract Introduction: Tumor-infiltrating lymphocytes (TIL) in tumor stroma are considered to be in...
Inflammatory cells are involved in tumour initiation and progression. In parallel, the adaptive immu...
Tumour infiltrating lymphocytes influence colorectal cancer (CRC) progression. However, lymphocyte i...
Tumor-infiltrating lymphocytes (TILs) are vital elements of the tumor microenvironment (TME), and th...
Background: Colorectal cancer (CRC) is globally the second most common form of cancer among women, a...
Accumulating evidence demonstrates an association between dense infiltration of lymphocytes and prog...
Cancer-related immunity has been identified as playing a key role in the outcome of colorectal cance...
Worldwide, more than one million people are diagnosed with colorectal cancer (CRC) every year. Analy...
The anti-tumour immune response is critical to patient prognosis in colorectal cancer (CRC). The aim...
The anti-tumour immune response is critical to patient prognosis in colorectal cancer (CRC). The aim...
Background: Although high T cell density is a strong favourable prognostic factor in colorectal canc...
Several distinct innate lymphoid cell (ILC) populations have been recently identified and shown to p...
Colorectal cancer (CRC) patients survive and stay free of disease for longer after surgery if their...
Solid tumours are commonly infiltrated by several immune cells [1-3]. In cancer, immune cells play c...
Objective: This study aimed to evaluate the immunohistochemical expression of forkhead boxP3 (Foxp3)...